JAK1 and folliculitis: The JAK1i group exhibited higher rates of acne, folliculitis, viral warts, and herpes zoster than the IL-13Ab group, reflecting the broader immunosuppressive effects of JAK1 inhibition, including impaired type I and II interferon signaling crucial for antiviral defense (30).